Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by heterogeneous clinical manifestations involving virtually the entire body. The pain in SLE can have different causes. The SLE classification criteria include mainly the musculoskeletal manifestations of pain, which are commonly reported as initial symptoms of SLE, such as arthralgia, arthritis and/or myalgia. Chronic widespread pain, which is typical of fibromyalgia (FM), is frequently associated with SLE. The aim of this review is to describe widespread pain and fatigue in SLE, and the association of SLE and FM. Although secondary FM is not correlated with the disease activity, it may interfere with the daily activities of SLE patients. Therefore it is necessary to identify its symptoms and treat them promptly to improve the quality of life of patients. In conclusion, it is essential to identify the origin of pain in SLE in order to avoid dangerous over-treatment in patients with co-existing widespread pain and FM.

Pain and systemic lupus erythematosus / M. Di Franco, M.P. Guzzo, F.R. Spinelli, F. Atzeni, P. Sarzi-Puttini, F. Conti, C. Iannuccelli. - In: REUMATISMO. - ISSN 0048-7449. - 66:1(2014 Jun), pp. 33-38.

Pain and systemic lupus erythematosus

F. Atzeni;P. Sarzi-Puttini;
2014

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by heterogeneous clinical manifestations involving virtually the entire body. The pain in SLE can have different causes. The SLE classification criteria include mainly the musculoskeletal manifestations of pain, which are commonly reported as initial symptoms of SLE, such as arthralgia, arthritis and/or myalgia. Chronic widespread pain, which is typical of fibromyalgia (FM), is frequently associated with SLE. The aim of this review is to describe widespread pain and fatigue in SLE, and the association of SLE and FM. Although secondary FM is not correlated with the disease activity, it may interfere with the daily activities of SLE patients. Therefore it is necessary to identify its symptoms and treat them promptly to improve the quality of life of patients. In conclusion, it is essential to identify the origin of pain in SLE in order to avoid dangerous over-treatment in patients with co-existing widespread pain and FM.
Chronic widespread pain; Fatigue; Fibromyalgia; Pain; Systemic lupus erythematosus; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Central Nervous System Sensitization; Comorbidity; Diagnosis, Differential; Fatigue; Fibromyalgia; Humans; Lupus Erythematosus, Systemic; Pain; Pain Management; Pain Perception; Quality of Life; Rheumatology
Settore MED/16 - Reumatologia
giu-2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
document (4).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 228.35 kB
Formato Adobe PDF
228.35 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/643192
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 26
  • ???jsp.display-item.citation.isi??? ND
social impact